Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers from the CIMA of the University of Navarra have discovered a possible cause of thrombosis

16.01.2007
A team of researchers from the CIMA of the University of Navarra has discovered a possible cause of thrombosis, and has developed a new diagnostic test for this disease.

The scientific project was undertaken in the Hemostasis and Thrombosis Laboratory. Based on this advance, Digna Biotech, the biotechnology firm that develops the patents obtained by the CIMA, has signed an agreement with the pharmaceutical firm Ferrer Internacional. This alliance will permit the commercialization, perhaps this year, of the new diagnostic test.

Thrombosis is a disease provoked by the appearance of a thrombus or blood clot, which totally or partially blocks the flow of blood. This pathology constitutes one of the principal causes of death. The researchers from the area of Cardiovascular Sciences of the CIMA base the new diagnostic test on the detection of EPCR antibodies, a substance that protects the blood vessels against obstruction by a thrombus.

Useful for young women suffering heart attack or multiple miscarriages

... more about:
»CIMA »Navarra »thrombosis

At the moment, this diagnostic test may be useful in the treatment of young women who have suffered a myocardial infarction or who have suffered multiple miscarriages due to thrombosis in the placenta. Research is continuing concerning other pathologies, where the biological basis of the disease is thrombosis, such as strokes and pulmonary embolisms. In the future, the new test may serve to design more effective antithrombotic treatments.

The project’s scientists explained that the C protein system constitutes one of the principal mechanisms for avoiding thrombosis in humans, and that the presence of the endothelial protein receptor C (EPCR) is necessary for its correct functioning. The researchers from the CIMA of the University of Navarra have demonstrated the existence of anti-EPCR autoantibodies which impede the antithrombotic function of this system. In addition, they have demonstrated that elevated levels of anti-EPCR antibodies in the serum and plasma of the patients is related to an increased risk of suffering new thrombotic phenomena.

Irati Kortabitarte | alfa
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&hizk=I&Berri_Kod=1149

Further reports about: CIMA Navarra thrombosis

More articles from Life Sciences:

nachricht More genes are active in high-performance maize
19.01.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht How plants see light
19.01.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>